BioSpace News Archive

Companies will collaborate on AI solutions supporting the delivery of seamless, distributed pregnancy care

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced that Bassil Dahiyat, Ph.D., president and chief executive officer, will participate in a fireside chat at the 2020 RBC Capital Markets Global Healthcare Virtual Conference on Wednesday, May 20, 2020 at 4:15 p.m. ET / 1:15 p.m. PT. A l

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced it has been issued a new patent (no. 10,646,456) by the United States Patent and Trademark Office (USPTO) that covers GOCOVRI ® (amantadine) extended release capsules. The new patent covers a method of reducing ‘OFF’ time and increasing ‘good ON

Allium Medical (TASE: ALMD), an Israeli medical device company, specializes in minimally invasive technologies subsidiary, TruLeaf Medical , has successfully tested a novel approach for transcatheter mitral valve replacement in patients suffering from severe mitral valve regurgitation during a long-term trial on large animals

Double Black Imaging (DBI) today announced the immediate availability of two radiology-focused medical-grade displays from LG Electronics bundled with DBI’s comprehensive calibration software package.

Next Generation Sequencing or NGS is an outstanding technology that arranges massive DNA strands through enormous parallelization.

Further Solidifies Merck Animal Health’s Position in the U.S. Companion Animal Category with Comprehensive, Continuous Parasite Protection

Hansa Biopharma has been invited to participate in five healthcare conferences during May and June including UBS Global Healthcare Conference, RBC Global Healthcare Conference, ABG Life Science Summit, Redeye Orphan Drug Event and Citi’s European Healthcare Conference

Mesoblast Limited, a leader in cellular medicines for inflammatory diseases, announced that it has successfully completed a capital raising of US$90 million¹ via a private placement of 43 million shares to existing and new institutional investors at a price of A$3.20 per share.

PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, today announced its financial results for the first quarter ended March 31, 2020 and provided a business update. First Quarter 2020 and Recent Business Highlights Initiated novel vaccine development programs for